The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global IVIG market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for IVIG is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for IVIG is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of IVIG include Green Cross, BSV, Hualan Bio, RAAS, YUAN DA SHUYANG, Kangbao Bio, Tiantan Bio, Taibang Bio and Weiguang Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for IVIG, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVIG.
Report Scope
The IVIG market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVIG market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVIG manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP
Segment by Type
Injection IVIG
Lyophilized Powder IVIG
Segment by Application
Multiple Sclerosis(MS)
Myasthenia Gravis(MG)
Multifocal Motor Neuropathy(MMN)
Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Dermatomyositis
Polymyositis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of IVIG manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of IVIG in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global IVIG market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for IVIG is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for IVIG is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of IVIG include Green Cross, BSV, Hualan Bio, RAAS, YUAN DA SHUYANG, Kangbao Bio, Tiantan Bio, Taibang Bio and Weiguang Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for IVIG, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVIG.
Report Scope
The IVIG market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVIG market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVIG manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP
Segment by Type
Injection IVIG
Lyophilized Powder IVIG
Segment by Application
Multiple Sclerosis(MS)
Myasthenia Gravis(MG)
Multifocal Motor Neuropathy(MMN)
Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Dermatomyositis
Polymyositis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of IVIG manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of IVIG in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 IVIG Market Overview
1.1 Product Overview and Scope of IVIG
1.2 IVIG Segment by Type
1.2.1 Global IVIG Market Value Comparison by Type (2024-2030)
1.2.2 Injection IVIG
1.2.3 Lyophilized Powder IVIG
1.3 IVIG Segment by Application
1.3.1 Global IVIG Market Value by Application: (2024-2030)
1.3.2 Multiple Sclerosis(MS)
1.3.3 Myasthenia Gravis(MG)
1.3.4 Multifocal Motor Neuropathy(MMN)
1.3.5 Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
1.3.6 Dermatomyositis
1.3.7 Polymyositis
1.4 Global IVIG Market Size Estimates and Forecasts
1.4.1 Global IVIG Revenue 2019-2030
1.4.2 Global IVIG Sales 2019-2030
1.4.3 Global IVIG Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 IVIG Market Competition by Manufacturers
2.1 Global IVIG Sales Market Share by Manufacturers (2019-2024)
2.2 Global IVIG Revenue Market Share by Manufacturers (2019-2024)
2.3 Global IVIG Average Price by Manufacturers (2019-2024)
2.4 Global IVIG Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IVIG, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IVIG, Product Type & Application
2.7 IVIG Market Competitive Situation and Trends
2.7.1 IVIG Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest IVIG Players Market Share by Revenue
2.7.3 Global IVIG Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 IVIG Retrospective Market Scenario by Region
3.1 Global IVIG Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global IVIG Global IVIG Sales by Region: 2019-2030
3.2.1 Global IVIG Sales by Region: 2019-2024
3.2.2 Global IVIG Sales by Region: 2025-2030
3.3 Global IVIG Global IVIG Revenue by Region: 2019-2030
3.3.1 Global IVIG Revenue by Region: 2019-2024
3.3.2 Global IVIG Revenue by Region: 2025-2030
3.4 North America IVIG Market Facts & Figures by Country
3.4.1 North America IVIG Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America IVIG Sales by Country (2019-2030)
3.4.3 North America IVIG Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe IVIG Market Facts & Figures by Country
3.5.1 Europe IVIG Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe IVIG Sales by Country (2019-2030)
3.5.3 Europe IVIG Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IVIG Market Facts & Figures by Country
3.6.1 Asia Pacific IVIG Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific IVIG Sales by Country (2019-2030)
3.6.3 Asia Pacific IVIG Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America IVIG Market Facts & Figures by Country
3.7.1 Latin America IVIG Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America IVIG Sales by Country (2019-2030)
3.7.3 Latin America IVIG Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa IVIG Market Facts & Figures by Country
3.8.1 Middle East and Africa IVIG Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa IVIG Sales by Country (2019-2030)
3.8.3 Middle East and Africa IVIG Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IVIG Sales by Type (2019-2030)
4.1.1 Global IVIG Sales by Type (2019-2024)
4.1.2 Global IVIG Sales by Type (2025-2030)
4.1.3 Global IVIG Sales Market Share by Type (2019-2030)
4.2 Global IVIG Revenue by Type (2019-2030)
4.2.1 Global IVIG Revenue by Type (2019-2024)
4.2.2 Global IVIG Revenue by Type (2025-2030)
4.2.3 Global IVIG Revenue Market Share by Type (2019-2030)
4.3 Global IVIG Price by Type (2019-2030)
5 Segment by Application
5.1 Global IVIG Sales by Application (2019-2030)
5.1.1 Global IVIG Sales by Application (2019-2024)
5.1.2 Global IVIG Sales by Application (2025-2030)
5.1.3 Global IVIG Sales Market Share by Application (2019-2030)
5.2 Global IVIG Revenue by Application (2019-2030)
5.2.1 Global IVIG Revenue by Application (2019-2024)
5.2.2 Global IVIG Revenue by Application (2025-2030)
5.2.3 Global IVIG Revenue Market Share by Application (2019-2030)
5.3 Global IVIG Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Green Cross
6.1.1 Green Cross Corporation Information
6.1.2 Green Cross Description and Business Overview
6.1.3 Green Cross IVIG Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Green Cross IVIG Product Portfolio
6.1.5 Green Cross Recent Developments/Updates
6.2 BSV
6.2.1 BSV Corporation Information
6.2.2 BSV Description and Business Overview
6.2.3 BSV IVIG Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BSV IVIG Product Portfolio
6.2.5 BSV Recent Developments/Updates
6.3 Hualan Bio
6.3.1 Hualan Bio Corporation Information
6.3.2 Hualan Bio Description and Business Overview
6.3.3 Hualan Bio IVIG Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hualan Bio IVIG Product Portfolio
6.3.5 Hualan Bio Recent Developments/Updates
6.4 RAAS
6.4.1 RAAS Corporation Information
6.4.2 RAAS Description and Business Overview
6.4.3 RAAS IVIG Sales, Revenue and Gross Margin (2019-2024)
6.4.4 RAAS IVIG Product Portfolio
6.4.5 RAAS Recent Developments/Updates
6.5 YUAN DA SHUYANG
6.5.1 YUAN DA SHUYANG Corporation Information
6.5.2 YUAN DA SHUYANG Description and Business Overview
6.5.3 YUAN DA SHUYANG IVIG Sales, Revenue and Gross Margin (2019-2024)
6.5.4 YUAN DA SHUYANG IVIG Product Portfolio
6.5.5 YUAN DA SHUYANG Recent Developments/Updates
6.6 Kangbao Bio
6.6.1 Kangbao Bio Corporation Information
6.6.2 Kangbao Bio Description and Business Overview
6.6.3 Kangbao Bio IVIG Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kangbao Bio IVIG Product Portfolio
6.6.5 Kangbao Bio Recent Developments/Updates
6.7 Tiantan Bio
6.6.1 Tiantan Bio Corporation Information
6.6.2 Tiantan Bio Description and Business Overview
6.6.3 Tiantan Bio IVIG Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tiantan Bio IVIG Product Portfolio
6.7.5 Tiantan Bio Recent Developments/Updates
6.8 Taibang Bio
6.8.1 Taibang Bio Corporation Information
6.8.2 Taibang Bio Description and Business Overview
6.8.3 Taibang Bio IVIG Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Taibang Bio IVIG Product Portfolio
6.8.5 Taibang Bio Recent Developments/Updates
6.9 Weiguang Bio
6.9.1 Weiguang Bio Corporation Information
6.9.2 Weiguang Bio Description and Business Overview
6.9.3 Weiguang Bio IVIG Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Weiguang Bio IVIG Product Portfolio
6.9.5 Weiguang Bio Recent Developments/Updates
6.10 SIBP
6.10.1 SIBP Corporation Information
6.10.2 SIBP Description and Business Overview
6.10.3 SIBP IVIG Sales, Revenue and Gross Margin (2019-2024)
6.10.4 SIBP IVIG Product Portfolio
6.10.5 SIBP Recent Developments/Updates
6.11 TONROL
6.11.1 TONROL Corporation Information
6.11.2 TONROL IVIG Description and Business Overview
6.11.3 TONROL IVIG Sales, Revenue and Gross Margin (2019-2024)
6.11.4 TONROL IVIG Product Portfolio
6.11.5 TONROL Recent Developments/Updates
6.12 RUIDE Bio
6.12.1 RUIDE Bio Corporation Information
6.12.2 RUIDE Bio IVIG Description and Business Overview
6.12.3 RUIDE Bio IVIG Sales, Revenue and Gross Margin (2019-2024)
6.12.4 RUIDE Bio IVIG Product Portfolio
6.12.5 RUIDE Bio Recent Developments/Updates
6.13 BOYA Bio
6.13.1 BOYA Bio Corporation Information
6.13.2 BOYA Bio IVIG Description and Business Overview
6.13.3 BOYA Bio IVIG Sales, Revenue and Gross Margin (2019-2024)
6.13.4 BOYA Bio IVIG Product Portfolio
6.13.5 BOYA Bio Recent Developments/Updates
6.14 RUIDE Bio
6.14.1 RUIDE Bio Corporation Information
6.14.2 RUIDE Bio IVIG Description and Business Overview
6.14.3 RUIDE Bio IVIG Sales, Revenue and Gross Margin (2019-2024)
6.14.4 RUIDE Bio IVIG Product Portfolio
6.14.5 RUIDE Bio Recent Developments/Updates
6.15 Xinxing Medicine
6.15.1 Xinxing Medicine Corporation Information
6.15.2 Xinxing Medicine IVIG Description and Business Overview
6.15.3 Xinxing Medicine IVIG Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Xinxing Medicine IVIG Product Portfolio
6.15.5 Xinxing Medicine Recent Developments/Updates
6.16 Weilun Bio
6.16.1 Weilun Bio Corporation Information
6.16.2 Weilun Bio IVIG Description and Business Overview
6.16.3 Weilun Bio IVIG Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Weilun Bio IVIG Product Portfolio
6.16.5 Weilun Bio Recent Developments/Updates
6.17 WIBP
6.17.1 WIBP Corporation Information
6.17.2 WIBP IVIG Description and Business Overview
6.17.3 WIBP IVIG Sales, Revenue and Gross Margin (2019-2024)
6.17.4 WIBP IVIG Product Portfolio
6.17.5 WIBP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IVIG Industry Chain Analysis
7.2 IVIG Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IVIG Production Mode & Process
7.4 IVIG Sales and Marketing
7.4.1 IVIG Sales Channels
7.4.2 IVIG Distributors
7.5 IVIG Customers
8 IVIG Market Dynamics
8.1 IVIG Industry Trends
8.2 IVIG Market Drivers
8.3 IVIG Market Challenges
8.4 IVIG Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
